Level I evidence
|
31 (15.1) |
11 (17.8) |
3 (6.6) |
10 (6.4) |
55 (13.5) |
26 (9.4) |
13 (18.4) |
2 (2.8) |
1 (4.3) |
2 (25.0) |
4 (2.0) |
Clinical practice guidelines |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
Systematic reviews |
8 (3.9) |
5 (8.1) |
2 (4.4) |
3 (1.9) |
17 (4.2) |
19 (6.9) |
6 (8.5) |
1 (1.9) |
0 (0.0) |
0 (0.0) |
2 (1.0) |
Randomized controlled trials |
23 (11.2) |
6 (9.7) |
1 (2.2) |
7 (4.5) |
35 (8.6) |
7 (2.5) |
6 (8.5) |
1 (1.9) |
1 (4.3) |
2 (25.0) |
2 (1.0) |
Quasi-randomized controlled trials |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
3 (0.7) |
0 (0.0) |
1 (1.4) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
Level II evidence
|
144 (69.9) |
45 (72.5) |
38 (84.4) |
128 (81.4) |
215 (52.9) |
184 (66.4) |
44 (61.9) |
43 (82.8) |
18 (78.2) |
6 (75.0) |
50 (25.6) |
Diagnostic accuracy studies |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
Cohort studies |
11 (5.3) |
2 (3.2) |
4 (8.9) |
6 (3.8) |
10 (2.5) |
9 (3.2) |
5 (7.0) |
8 (15.4) |
2 (8.7) |
1 (12.5) |
1 (0.5) |
Cross-sectional studies |
103 (50.0) |
27 (43.5) |
32 (71.1) |
95 (60.5) |
137 (33.7) |
91 (32.9) |
21 (29.6) |
24 (46.2) |
14 (60.9) |
3 (37.5) |
38 (19.5) |
Non-randomized controlled trials |
11 (5.3) |
5 (8.1) |
1 (2.2) |
12 (7.6) |
16 (3.9) |
6 (2.2) |
2 (2.8) |
3 (5.8) |
1 (4.3) |
0 (0.0) |
2 (1.0) |
Case-control studies |
2 (1.0) |
2 (3.2) |
0 (0.0) |
1 (0.6) |
2 (0.5) |
2 (0.7) |
1 (1.4) |
1 (1.9) |
0 (0.0) |
1 (12.5) |
0 (0.0) |
Single-case or case-series studies |
17 (8.3) |
9 (14.5) |
1 (2.2) |
14 (8.9) |
50 (12.3) |
76 (27.4) |
15 (21.1) |
7 (13.5) |
1 (4.3) |
1 (12.5) |
9 (4.6) |
Level III evidence
|
31 (15.1) |
6 (9.7) |
4 (8.8) |
19 (12.0) |
136 (33.4) |
67 (24.2) |
14 (19.6) |
7 (13.5) |
4 (17.3) |
0 (0.0) |
141 (72.2) |
Cadaveric or animal experimental studies |
6 (2.9) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
54 (13.3) |
10 (3.6) |
5 (7.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
5 (2.6) |
Narrative reviews |
16 (7.8) |
5 (8.1) |
1 (2.2) |
13 (8.3) |
43 (10.6) |
35 (12.6) |
5 (7.0) |
3 (5.8) |
3 (13.0) |
0 (0.0) |
16 (8.2) |
Development, translation, cross-cultural adaptation, and
measurement properties of any measurement tool |
3 (1.5) |
1 (1.6) |
2 (4.4) |
4 (2.5) |
35 (8.6) |
20 (7.2) |
3 (4.2) |
4 (7.7) |
0 (0.0) |
0 (0.0) |
7 (3.6) |
Technical notes describing surgical procedures or anatomical
findings |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
Professional quiz |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
Editorials |
1 (0.5) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
88 (45.1) |
Letter to the editor |
5 (2.4) |
0 (0.0) |
0 (0.0) |
1 (0.6) |
1 (0.2) |
1 (0.4) |
1 (1.4) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
3 (1.5) |
Clinical comments |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
1 (4.3) |
0 (0.0) |
3 (1.5) |
Reflections of attitudes in clinical practice |
0 (0.0) |
0 (0.0) |
1 (2.2) |
1 (0.6) |
0 (0.0) |
1 (0.4) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
14 (7.2) |
Experts opinions |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
3 (1.5) |
Other |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
3 (0.7) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
2 (1.0) |
Total Number of articles (%)
|
206 (13.7) |
62 (4.1) |
45 (3.0) |
157 (10.4) |
406 (27.0) |
277 (18.4) |
71 (4.7) |
52 (3.4) |
23 (1.5) |
8 (0.5) |
195 (12.9) |